138 related articles for article (PubMed ID: 23433498)
21. Quality of life is decreased in patients with paragangliomas.
van Hulsteijn LT; Louisse A; Havekes B; Kaptein AA; Jansen JC; Hes FJ; Smit JW; Corssmit EP
Eur J Endocrinol; 2013 May; 168(5):689-97. PubMed ID: 23392211
[TBL] [Abstract][Full Text] [Related]
22. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia.
Gill AJ
Pathology; 2012 Jun; 44(4):285-92. PubMed ID: 22544211
[TBL] [Abstract][Full Text] [Related]
23. Clinical and molecular progress in hereditary paraganglioma.
Baysal BE
J Med Genet; 2008 Nov; 45(11):689-94. PubMed ID: 18978332
[TBL] [Abstract][Full Text] [Related]
24. Improving Outcomes in Carotid Body Tumors Treatment: The Impact of a Multidisciplinary Team Approach.
Menegolo M; Xodo A; Bozza R; Piazza M; Pirri C; Caroccia B; Schiavi F; Opocher G; Antonello M; Grego F
Ann Vasc Surg; 2021 Aug; 75():315-323. PubMed ID: 33556521
[TBL] [Abstract][Full Text] [Related]
25. Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients.
Bayley JP; Weiss MM; Grimbergen A; van Brussel BT; Hes FJ; Jansen JC; Verhoef S; Devilee P; Corssmit EP; Vriends AH
Endocr Relat Cancer; 2009 Sep; 16(3):929-37. PubMed ID: 19546167
[TBL] [Abstract][Full Text] [Related]
26. Novel SDHD germ-line mutations in pheochromocytoma patients.
Neumayer C; Moritz A; Asari R; Weinhäusel A; Hölzenbein T; Kretschmer G; Niederle B; Haas OA
Eur J Clin Invest; 2007 Jul; 37(7):544-51. PubMed ID: 17576205
[TBL] [Abstract][Full Text] [Related]
27. Familial paraganglioma syndromes.
Chetty R
J Clin Pathol; 2010 Jun; 63(6):488-91. PubMed ID: 20498024
[TBL] [Abstract][Full Text] [Related]
28. A multicenter review of carotid body tumour management.
Sajid MS; Hamilton G; Baker DM;
Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):127-30. PubMed ID: 17400487
[TBL] [Abstract][Full Text] [Related]
29. The presence of SDHB mutations should modify surgical indications for carotid body paragangliomas.
Ellis RJ; Patel D; Prodanov T; Nilubol N; Pacak K; Kebebew E
Ann Surg; 2014 Jul; 260(1):158-62. PubMed ID: 24169168
[TBL] [Abstract][Full Text] [Related]
30. Malignant paraganglioma caused by a novel germline mutation of the succinate dehydrogenase D-gene--a case report.
Papaspyrou K; Rossmann H; Fottner C; Weber MM; Mann W; Lackner KJ; Helling K
Head Neck; 2008 Jul; 30(7):964-9. PubMed ID: 18213727
[TBL] [Abstract][Full Text] [Related]
31. Cervical paragangliomas: is SDH genetic analysis systematically required?
Fakhry N; Niccoli-Sire P; Barlier-Seti A; Giorgi R; Giovanni A; Zanaret M
Eur Arch Otorhinolaryngol; 2008 May; 265(5):557-63. PubMed ID: 17987308
[TBL] [Abstract][Full Text] [Related]
32. Avoiding and nonexpressing: coping styles of patients with paragangliomas.
van Hulsteijn LT; Kaptein AA; Louisse A; Smit JW; Corssmit EP
J Clin Endocrinol Metab; 2013 Sep; 98(9):3608-14. PubMed ID: 23969183
[TBL] [Abstract][Full Text] [Related]
33. Head and Neck Paraganglioma Atypically Carrying a Succinate Dehydrogenase Subunit B Mutation (L157X).
Takeshima K; Ariyasu H; Uraki S; Kitahara C; Morita S; Inaba H; Iwakura H; Warigaya K; Murata SI; Yamazaki Y; Sasano H; Akamizu T
Intern Med; 2020 May; 59(9):1167-1171. PubMed ID: 32023584
[TBL] [Abstract][Full Text] [Related]
34. SDHB, SDHC, and SDHD mutation screen in sporadic and familial head and neck paragangliomas.
Mhatre AN; Li Y; Feng L; Gasperin A; Lalwani AK
Clin Genet; 2004 Nov; 66(5):461-6. PubMed ID: 15479192
[TBL] [Abstract][Full Text] [Related]
35. Identification of a 4.9-kilo base-pair Alu-mediated founder SDHD deletion in two extended paraganglioma families from Austria.
Janecke AR; Willett-Brozick JE; Karas C; Hasipek M; Loeffler-Ragg J; Baysal BE
J Hum Genet; 2010 Mar; 55(3):182-5. PubMed ID: 20111059
[TBL] [Abstract][Full Text] [Related]
36. Role of rapid sequence whole-body MRI screening in SDH-associated hereditary paraganglioma families.
Jasperson KW; Kohlmann W; Gammon A; Slack H; Buchmann L; Hunt J; Kirchhoff AC; Baskin H; Shaaban A; Schiffman JD
Fam Cancer; 2014 Jun; 13(2):257-65. PubMed ID: 23934599
[TBL] [Abstract][Full Text] [Related]
37. Clinical features of paraganglioma syndromes.
Boedeker CC; Neumann HP; Offergeld C; Maier W; Falcioni M; Berlis A; Schipper J
Skull Base; 2009 Jan; 19(1):17-25. PubMed ID: 19568339
[TBL] [Abstract][Full Text] [Related]
38. Outcomes of annual surveillance imaging in an adult and paediatric cohort of succinate dehydrogenase B mutation carriers.
Tufton N; Shapiro L; Srirangalingam U; Richards P; Sahdev A; Kumar AV; McAndrew L; Martin L; Berney D; Monson J; Chew SL; Waterhouse M; Druce M; Korbonits M; Metcalfe K; Drake WM; Storr HL; Akker SA
Clin Endocrinol (Oxf); 2017 Feb; 86(2):286-296. PubMed ID: 27678251
[TBL] [Abstract][Full Text] [Related]
39. [Head and neck paragangliomas: revision of 89 cases in 73 patients].
Sevilla García MA; Llorente Pendás JL; Rodrigo Tapia JP; García Rostán G; Suárez Fente V; Coca Pelaz A; Suárez Nieto C
Acta Otorrinolaringol Esp; 2007 Mar; 58(3):94-100. PubMed ID: 17371691
[TBL] [Abstract][Full Text] [Related]
40. Germline mutations in PTEN and SDHC in a woman with epithelial thyroid cancer and carotid paraganglioma.
Zbuk KM; Patocs A; Shealy A; Sylvester H; Miesfeldt S; Eng C
Nat Clin Pract Oncol; 2007 Oct; 4(10):608-12. PubMed ID: 17898811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
